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ABSTRACT 
Background:  Attention  deficit/hyperactivity  disorder  (ADHD)  is  one  of  the  commonest 
psychiatric  disorders  in  children  and  adolescents.  The  main  symptoms  of  ADHD  are 
hyperactivity, inattention and impulsivity. Both etiology and neurobiological basis of ADHD 
are unknown. In this context, long-chain polyunsaturated fatty acids (LC-PUFAs), especially 
omega-3 (n-3) PUFAs, have become a focus of interest. The symptoms of ADHD have been 
suggested to be associated with a deficiency of n-3 PUFAs. In addition, the impact of a 
supply of dietary n-3 PUFAs in the treatment of ADHD has frequently been discussed. 
 
Objective:  The  aim  of  the  present  study  was  to  examine  the  influence  of  n-3  PUFA 
supplementation on attention and impulsivity in the spontaneously hypertensive rat (SHR) 
which has been proposed to be a valid genetic animal model of ADHD.  
 
Methods: Seven-week-old male SHRs were randomly divided into two groups of 15 rats and 
fed one of two experimental diets (n-3 PUFA-enriched or n-3 PUFA-deficient) prior to and 
during  behavioral  testing.  Attention  and  impulsivity  were  assessed  using  a  three-choice-
serial-reaction-time-task (3CSRTT) which is based on the five-choice-serial-reaction-time-
task. The experiment was performed with three-month-old rats.  
 
Results: Our findings demonstrate a marked difference between groups regarding impulsivity 
but not attention. The n-3 PUFA-enriched diet significantly reduced impulsivity in SHRs 
compared with rats fed with the n-3 PUFA-deficient diet. 
 
Conclusion: The present data show a decrease in impulsivity following a dietary n-3 PUFA 
supplementation, but no changes in attention. A possible explanation for these results is that 
the attention displayed by SHR may not be linked to n-3 PUFA supply. It is important to note 
that inattention and impulsiveness are two of the main symptoms of ADHD. Our results Functional Foods in Health and Disease 2014; 4(7):285-298                                                      Page 286 of 298 
 
 
regarding  dietary  n-3  PUFA  supply  may  support  the  positive  findings  in  human  studies 
demonstrating  that  n-3  PUFA  administration  can  improve  the  cognitive  or  behavioral 
symptoms in children with ADHD. 
 
Key words: omega-3 polyunsaturated fatty acid, animal model, spontaneously hypertensive 
rat, attention, impulsivity, attention deficit/hyperactivity disorder 
 
 
INTRODUCTION: 
Attention-deficit/hyperactivity  disorder  (ADHD)  is  one  of  the  most  frequently  diagnosed 
psychiatric disorders of childhood and adolescence [1, 2]. This mental disorder affects about 
3-5 % of all children and adolescents [3]. According to the recently published 5th edition of 
the  Diagnostic  and  Statistical  Manual  of  Mental  Disorders  (DSM-5)  [4],  ADHD  has  a 
relatively heterogeneous clinical profile which manifests itself before the twelfth year of life. 
This disorder is characterized by excessive motor activity, inattention with an increase in 
distractibility,  impulsiveness  and  disturbances  of  psychosocial  adaptation  [5-8]. 
Dysfunctioning  of  noradrenergic  and  dopaminergic  neurotransmission  appears  to  play  an 
important  role  in  the  pathophysiology  for  ADHD  [9-12].  The  etiology  and  underlying 
neurobiology are still unknown [13].  
Nutrition including the role of long-chain polyunsaturated fatty acids (LC-PUFAs) has 
become  a  focus  of  debate  regarding  the  possible  causes  of  ADHD.  LC-PUFAs  such  as 
omega-6 (n-6) and omega-3 (n-3) PUFAs play a significant role in the development and 
functioning of the brain [14]. Deficits and imbalances of these fatty acids can therefore have a 
significant impact on mental illness [15]. In this context, LC-PUFAs have become a focus of 
research interest in ADHD [15].  
Some studies have shown that blood plasma n-3 PUFA levels are reduced in children and 
adults  with  symptoms  of  ADHD  [16,  17].  These  deficits  are  also  linked  to  behavioral 
problems and learning difficulties [18]. In comparison with a control group, decreased levels 
of  arachidonic  acid  (AA,  C20:4  n-6)  and  docosahexaenoic  acid  (DHA,  C22:6  n-3)  were 
found  in  erythrocytes  of  children  and  adolescents  with  ADHD  [16,  17,  19,  20].  Further 
studies could demonstrate an increase in the ratio of n-6/n-3 PUFA (AA/eicosapentaenoic 
acid (EPA, C20:5 n-3)) in the plasma of children and adults with ADHD [16, 17, 21]. In 
addition, supplementation studies with LC-PUFA found improvements in behavioral ratings 
[22-24]  which  were  associated  with  a  decrease  in  the  plasma  AA/EPA  ratio  [24]. 
Randomized controlled experiments have shown that n-3 PUFA administration can reduce 
impulsivity  and  attention  problems  in  children  with  ADHD  symptoms  compared  with  a 
placebo group [25-28].  
Human studies have suggested a link between n-3 PUFAs and ADHD [e.g. 18]. Humans 
are  incapable  of  synthesizing  PUFAs  and  dietary  intake  is  therefore  necessary  [29,  30]. 
However, it is difficult to regulate PUFA ingestion in humans and a possible connection 
between n-3 PUFAs and ADHD can be more easily assessed in animal studies. It has been 
shown  that  long-term  deficiency  of  n-3  PUFAs  in  rats  causes  changes  in  central 
dopaminergic neurotransmission [31-33]. Dopamine appears to play an important role in the 
neurobiology of ADHD [34]. In addition, major alterations caused by an n-3 PUFA shortage 
were observed in the frontal cortex of animals  [32].  The underlying mechanisms are not Functional Foods in Health and Disease 2014; 4(7):285-298                                                      Page 287 of 298 
 
 
completely  understood.  Altered  neurotransmission  seems  to  be  caused  by  changes  in  the 
concentration of LC-PUFAs in the neuronal membrane [35, 36]. 
Several studies have shown that n-3 PUFA deficiency in rodents is associated with an 
increase in activity [37, 38], impairments in spatial learning [39, 40], working memory [41] 
and olfactory discrimination learning [42] as well as with aggression and depression [43]. 
These findings suggest that a depletion of n-3 PUFAs has an influence on cognitive processes 
and behavior. Chalon et al. [44] demonstrated that n-3 PUFA supplementation reduced motor 
activity in rats. Carrie et al. [45] showed that the intake of n-3 PUFAs leads to a decrease in 
locomotor  activity  among  older  mice.  In  addition,  a  marked  difference  in  open  field 
locomotor activity was observed between spontaneously hypertensive rat (SHR) fed with n-3 
PUFA-deficient food and SHR on an n-3 PUFA-enriched diet [46]. Furthermore, several 
studies  observed  cognitive  improvements  in  n-3  PUFA-depleted  rats  receiving  a 
supplementation  diet  at  birth  and  after  weaning  [47-50].  Dervola  et  al.  [51]  have 
demonstrated  that  an  n-3  PUFA  supply  in  SHR  dams  decreases  the  non-reinforcement 
spontaneous locomotion and enhances the reinforcement-induced attention in the progeny of 
male SHRs. These investigations suggest that the supply of n-3 PUFAs can lead to a decrease 
in locomotor activity and may have some impact on cognitive performance in animals.  
However, only a few animal studies have investigated LC-PUFAs and behavior with 
regard to the ADHD main symptoms. A link has been demonstrated between n-3 PUFAs and 
changes in motor activity in animals [37, 38, 46]. To our knowledge, there is only one study 
that has assessed attention deficits, impulsivity and hyperactivity aspects [51]. Similarly, the 
beneficial effect of n-3 PUFA supplementation has not yet been demonstrated. Since ADHD 
has a genetic basis, more attention should be paid to genetic animal models of ADHD such as 
the SHR [52, 53], particularly as these rodents show a natural lack of DHA in their neuronal 
cell membranes [54].  
The aim of the present study was to investigate the effect of an n-3 PUFA-enriched diet 
versus an n-3 PUFA-deficient diet on attention and impulsivity in SHRs using the three-
choice-serial-reaction-time-task (3CSRTT).  
 
METHODS: 
Animals:  Seven-week-old  male  SHR  were  obtained  from  Charles  River  Laboratories 
(Sulzbach, Germany). They were kept in standard cages on a 12 h light-dark cycle (light from 
7:00 h – 19:00 h). Room temperature was maintained at 22 °C +/- 2 °C with an average 
humidity of 50 %. Water and food were provided ad libitum. Access to food was restricted 
during  behavioral  testing  in  order  to  increase  the  animals’  motivation.  Body  weight  was 
measured daily. A weight reduction of more than 10-15 % was avoided in order to prevent 
stress [55, 56] and subsequent changes in the dopaminergic system [57]. 
The  rats  were  randomly  divided  into  two  groups  of  15  rats  and  fed  one  of  two 
experimental diets from the day of their arrival and throughout the testing period (3CSRTT), 
i.e the diets were provided for a total of 16 weeks (six weeks after arrival and 10 weeks of 
testing). The two experimental diets, the n-3 PUFA-enriched (n-3 Rich) diet and the n-3 
PUFA-deficient (n-3 Def) diet, were prepared by Ssniff, Soest, Germany. Both diets were 
based  on  the  American  Institute  of  Nutrition–93  G  (AIN93G)  and  meet  all  the  current 
nutrition standards for rat growth [58]. The fatty acid composition of the diets is shown in 
Table 1. The diets were stored at –20 °C and provided fresh daily.  The experiment was 
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Table  1.  Fatty  acid  composition  of  the  experimental  diets  (Ssniff  Spezialdiäten,  Soest,    
Germany) 
 
  n-3 PUFA-enriched 
diet 
n-3 PUFA-deficient 
diet 
 
Energy (Atwater), MJ/kg* 
 
 
17.1 
 
17.1
 
kJ% protein 
 
18  18 
kJ% carbohydrates 
 
60  60 
kJ% Fat 
  22  22 
     
Fatty acids, % of the diet 
 
   
C 6:0 
 
0.05  0.05 
C 8:0 
 
0.59  0.62 
C 10:0  
 
0.47  0.49 
C 12:0 
 
3.48  3.64 
C 14:0 
 
1.35  1.41 
C 16:0 
 
0.84  0.85 
C 18:0 
 
0.29  0.28 
C 20:0 
 
0.01  0.01 
C 18:1 
 
0.82  0.77 
C 18:2 n6 
 
1.54  1.58 
C 18:3 n3 
 
0.27  0.01 
 
  * physiological fuel value 
 
Apparatus: The task is based on the five-choice-serial-reaction-time-task [59, 60]. In the 
present  study,  a  three-choice  variant  of  the  paradigm  was  used  (holes  no.  3,  5,  7).  The 
remaining unused holes were covered. The experiment was performed using four ventilated 
wooden  chambers  (Campden  Instruments,  Loughborough,  Leicestershire,  England)  which 
included four stainless steel boxes (26 x 26 cm horizontally and approximately 30 cm high). 
The task was performed with a house light (3-Watt light bulb), three cue holes (each about 2 
cm in diameter) with internal light-emitting diodes (3 Watt) and an illuminated food tray on 
the wall opposite to the cue holes. The three cue holes were arranged horizontally on one 
curved rear wall and placed about 2 cm from the floor (stainless steel grid). The distance 
between adjacent holes was 6 cm. Nose pokes into the cue holes and the food tray were 
registered by photocells. A correct response, consisting of a nose poke into a lit cue hole was 
rewarded with a food pellet (45 mg dustless sucrose pellets, Bio-Serv, Frenchtown, New 
Jersey,  USA),  which  was  delivered  into  the  food  tray.  Premature  responses  during  the 
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stimulus presentation (an omission) resulted in a 5-second time-out period in which the house 
light was turned off. The start of the next trial was signaled automatically by illumination of 
the house light and food tray, and began with a nose poke of the rats into the food tray. 
 
Procedure: The 3CSRTT comprised three phases – habituation (2 days), training (8 weeks) 
and test (5 days) (see Instruction Manual for MKII Rat 5CSRT [61]). After completion of the 
training, the stimulus duration was fixed at 2 s regardless of the performance. A session 
ended after either 30 minutes or 60 rewards, whichever occurred first. The ITIs were varied 
randomly between 1.5 s, 2.5 s, 3.5 s, 4.5 s (short ITI) in order to assess attention and between 
5.5 s, 6.5 s, 7.5s, 8.5 s (long ITI) to quantify impulsivity.  
 
Statistics: The following parameters concerning impulsive behavior were analyzed: rate of 
premature  responses  (ratio  of  number  of  premature  responses/total  number  of  trials 
completed), number of premature responses (nose poke responses during ITI), number of 
time-out responses (nose poke responses during time-out period). The following parameters 
concerning activity of responses were examined: total number of trials completed and total 
correct  and  incorrect  responses.  In addition,  the  following  parameters  regarding  attention 
were investigated: number of correct responses, number of commission errors (false reaction) 
and number of omission errors (missed reactions). Statistical analyses were performed using 
the nonparametric Mann-Whitney U-Test (between subjects design), an alpha level of 0.05 
was  applied.  A  mean  value  for  each  animal  was  calculated  in  order  to  compare  the 
differences  between  the  n-3  fatty  acid  groups.  The  analyses  were  carried  out  using  the 
statistical package PASW 18.0 for Windows. 
 
Ethics: The present experiment was carried out in accordance with the National Institutes of 
Health Guide for the Care  and Use of  Laboratory  Animals  (NIH publication No. 86-23, 
revised 1985). 
 
RESULTS:  
 
Body weight: The two experimental diets, i.e. n-3 Rich and n-3 Def, had no significant effect 
on the body weight of the rats (data not shown). 
 
3CSRTT:  In  regard  to  the  comparison  between  the  n-3  Rich  and  the  n-3  Def  groups, 
statistically significant differences were found in the “rate of premature responses”. The ratio 
of the number of premature responses to the total number of trials completed is significantly 
higher in the n-3 Def group than in the n-3 Rich rats. There are no significant differences in 
the nose poke responses during ITI and the number of time-out responses. However, the n-3 
Def rats showed more premature responses than those in the n-3 Rich group. Furthermore, the 
n-3 Rich group showed fewer nose poke responses during the time-out period than the n-3 
Def animals. All values regarding the rate of premature responses, the number of premature 
responses and the number of time-out responses of the n-3 Rich and the n-3 Def groups are 
given in Table 2. 
 
Table 2. Effects of n-3 PUFA deficiency and supplementation on impulsivity in the 3CSRTT 
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  Rate of  
premature responses 
Number of premature 
responses 
Number of time-out  
responses 
 
n-3 Rich 
group 
 
0.88 ± 0.34 
* 
 
13.65 ± 1.39 
 
10.07 ± 1.31 
 
n-3 Def 
group 
 
1.23 ± 0.20 
 
16.73 ± 1.87 
 
14.57 ± 1.79 
 
p-value 
 
0.007 
 
0.245 
 
0.085 
 
 
z-value 
 
 
-2.717 
 
-1.162 
 
-1.723 
 
n-3 Def group = n-3 PUFA-deficient group; n-3 Rich group = n-3 PUFA-enriched group;  
* p ≤ .05 compared to n-3 Def group; data are means ± standard errors for 15 rats per group 
  
The total number of trials completed is significantly higher in the n-3 Rich group than in 
the n-3 Def rats. Similarly, the total correct and incorrect responses were significantly higher 
in the n-3 Rich group than in the n-3 Def group. The total number of trials completed and the 
total correct and incorrect responses are presented in Table 3. 
 
Table 3. Effects of n-3 PUFA deficiency and supplementation on the activity of responses in 
the 3CSRTT test (long ITI) in SHR 
 
  Total number of trials 
completed 
Total correct and incorrect  
responses 
 
n-3 Rich group 
 
25.72  ± 2.05 
*  
 
22.33  ± 1.89 
* 
 
n-3 Def group 
 
19.36  ± 2.16  
 
16.67 ± 2 
 
p-value 
 
0.021 
 
0.034 
 
 
z-value 
 
2.302 
 
2.116 
 
n-3 Def group = n-3  PUFA-deficient group; n-3 Rich group = n-3 PUFA-enriched group;  
* p ≤ .05 compared to n-3 Def group; data are means ± standard errors for 15 rats per group 
                                                                                                                                              
There were no statistically significant differences concerning the number of correct responses 
or the number of commission and omission errors between groups. However, the n-3 Rich 
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Rich  group  made  fewer  commission  errors  and  more  omission  errors  than  the  n-3  Def 
animals. The number of correct responses, commission and omission errors of the n-3 Rich 
and the n-3 Def groups are given in Table 4. 
 
Table 4. Effects of n-3 PUFA enrichment and deficiency on attention in the 3CSRTT test 
(short ITI) in SHR 
 
  Number of correct  
responses 
Number of commission  
errors 
Number of omission  
errors 
 
n-3 Rich 
group 
 
23.32 ± 1.28 
 
2.79 ± 0.29 
 
7.68 ± 0.80 
 
n-3 Def 
group 
 
22.61 ± 1.44 
 
3.17 ± 0.34 
 
6.88 ± 0.77 
 
p-value 
 
0.852 
 
0.440 
 
0.262 
 
 
z-value 
 
 
0.187 
 
-0.771 
 
1.121 
 
n-3 Def group = n-3  PUFA-deficient group; n-3 Rich group = n-3 PUFA-enriched group;  
data are means ± standard errors for 15 rats per group 
 
DISCUSSION: 
Up until now the effects of n-3 PUFA supplementation on impulsive behavior and attention 
in rats have not sufficiently been investigated. The aim of the present study was therefore to 
elucidate the role of n-3 PUFAs by assessing impulsivity and attention in the SHR model 
with the 3CSRTT.  
In the testing phase, there were no significant differences in body weight between the 
two  n-3  groups.  The  differences  in  behavior  between  the  n-3  groups  are  therefore  not 
confounded by body weight. The present study attempted to investigate the effects of n-3 
PUFA supplementation  on impulsive  behavior in rats  as  measured with  the 3CSRTT.  In 
comparison  with  the  n-3  Def  rats,  the  n-3  Rich  diet  significantly  decreased  the  ratio  of 
number of premature responses to total number of trials completed. This data suggests that an 
n-3 PUFA diet can improve impulsive behavior in SHR. Similar findings were reported by a 
study that investigated the effect of n-3 PUFA supplementation on impulsivity in SHR [51].  
However,  the  choice-serial-reaction-time-task  (CSRTT)  assesses  more  parameters 
regarding impulsive behavior, i.e. the number of premature responses and the number of 
time-out responses. In regard to these factors no significant differences between n-3 groups 
were  observed,  although  both  parameters  may  show  some  improvements  concerning 
impulsive behavior. The n-3 Def rats made more premature responses and more nose poke 
responses  during  the  time-out  period  than  the  n-3  Rich  group.  This  may  indicate  that 
impulsive behavior was reduced by dietary n-3 PUFA supplementation. This profile of results 
is consistent with previous animal studies demonstrating a recovery from PUFA deficiency 
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nor the rate of time-out responses showed significant effects in the present study, our results 
call for further investigations. 
Possible effects of dietary n-3 PUFAs on impulsive behavior in rats were insufficiently 
examined in the past. Previous studies investigating the effects of impulsivity on behavior 
used premature responses as sole parameter [62, 63]. In our study, we suppose that it may be 
important to distinguish between impulsive premature responses and the generally increased 
response activity [64]. The CSRTT provides no valid parameters of the response activity. 
However, two parameters might indicate a general response activity, i.e. the total number of 
trials completed and  the  total  correct  and incorrect  responses.  The total number of trials 
completed is significantly higher in the n-3 Rich group than in the n-3 Def rats. In addition, 
the total correct and incorrect responses were significantly higher in the n-3 Rich group than 
in the n-3 Def group. Both parameters might show a significantly enhanced response activity 
of the n-3 Rich rats. One could say that rats fed with an n-3 PUFA-enriched diet show more 
rather than fewer answers, which may be associated with an enhanced motivation (being less 
“off-task”). 
Although the n-3 Rich rats were more active, as demonstrated by the total number of 
trials completed and the total correct and incorrect responses, they showed a significantly 
reduced premature behavior, as indicated by the “rate of premature responses”. Moreover, the 
most  commonly  discussed  parameters,  i.e.  the  number  of  premature  responses  and  the 
number  of  time-out  responses,  showed  an  effect  in  the  same  direction,  although  these 
comparisons  failed  to  be  statistically  significant.  These  findings  indicate  that  the  rats’ 
impulsive behavior cannot be seen as a simple result of an increase in activity [65]. Taken 
together, one may speculate that an n-3 PUFA supplementation cannot only reduce premature 
responses but can probably also increase the motivational state in the 3CSRTT. It would 
therefore be of interest to assess motivation and discuss it separately from impulsivity in 
future studies.  
In regard to the effect of n-3 PUFA supplementation on the cognitive performance in the 
3CSRTT, the present results indicate no significant improvements in attention in the SHR 
model. The attention parameters such as the number of correct responses and commission 
errors did not significantly differ between the n-3 groups.  
The exact timing of the n-3 PUFA supply may be seen as a factor responsible for the low 
level of responses concerning attention in the SHR following the n-3 PUFA-enriched diet. In 
our  study,  the  n-3  PUFA  supplementation  began  post-weaning.  A  certain  amount  of  n-3 
PUFAs is accumulated in the nervous system of adult mammals and an increase occurs in the 
prenatal and early postnatal period, namely during brain growth [66-68]. This leads us to 
assume that an enrichment of n-3 PUFAs in the SHR has more important effects prenatally 
than  in  the  post-weaning  period.  However,  the  aim  of  the  present  study  was  rather  to 
investigate the effect of supplementation in terms of treatment. Further studies using the SHR 
model, especially in the prenatal phase, appear to be worthwhile.  
In  summary,  one  could  conclude  that  the  n-3  PUFA-enriched  diet  reduced  the  rats’ 
impulsivity.  However,  dietary  n-3  PUFA  enrichment  was  compared  with  n-3  PUFA 
deficiency in this study. The question of whether or not an n-3 PUFA-deficient diet has some 
side-effects which can also influence the behavior of n-3 Def animals remains unanswered. It 
needs therefore to be investigated whether this effect can also be found when a balanced diet 
is used as control.  
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CONCLUSION: 
Taken  together,  the  present  findings  show  that  the  n-3  PUFA-enriched  diet  administered 
post -weaning had no significant effects on attention in SHRs as assessed in the 3CSRTT. In 
contrast, the data suggest a positive influence of the n-3 PUFA-enriched diet on impulsive 
behavior. Impulsiveness is one of main symptoms of ADHD. The present results may support 
the positive findings in previous human supplementation studies which demonstrated that the 
administration  of  n-3  PUFAs  might  improve  the  cognitive  or  behavioral  symptoms  in 
children with ADHD and may have some therapeutical effects [23, 24, 69-71].  
 
Abbreviations:  arachidonic  acid  (AA),  attention  deficit/hyperactivity  disorder  (ADHD), 
docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), long-chain polyunsaturated fatty 
acid (LC-PUFA), omega-3 polyunsaturated fatty acid (n-3 PUFA), omega-6 polyunsaturated 
fatty acid (n-6 PUFA), spontaneously hypertensive rat (SHR), three-choice-serial-reaction-
time-task (3CSRTT) 
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